Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients.
about
Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophagesExogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracisImmunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis.Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.Gene expression profiles of bronchoalveolar cells in pulmonary TBIn vitro differentiation of human macrophages with enhanced antimycobacterial activityInhaled therapeutics for prevention and treatment of pneumoniaVaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis.Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis.Extracellular traps and macrophages: new roles for the versatile phagocyte.New drugs and regimens for treatment of TB.Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.Management of multidrug-resistant tuberculosis: Update 2007.Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophagesInterleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophagesCytokine therapy of tuberculosis at the crossroads.Adjunct immunotherapies for tuberculosis.The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature.Host-directed therapeutics for tuberculosis: can we harness the host?Function and Potentials of M. tuberculosis EpitopesOptimization of conditions for expression of recombinant interferon-γ in E.coli.Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis.IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis.Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
P2860
Q28248983-FCB06B31-0009-4C09-9C1D-37473F745674Q28393848-20D6796F-3E27-4D92-B90C-597C0D78ADA8Q33503248-36E68136-1D16-4F5A-9021-81D3ABB8C879Q33730853-C2BF1DD4-1F25-40BC-AE4D-2F5EAE30721CQ34840811-3F68DC5D-C75E-42EB-9894-89DC006B1F17Q35150399-6CDCA979-E7CC-4F58-B35B-39C88A137CABQ35370163-C4BF9C9A-9B38-4284-89A3-3E4119C15D1EQ35925366-857CC618-2AF6-4352-9285-C9E3BE17D6B4Q35963115-B18CC1B7-0435-425F-8B6C-BD14491823E4Q36575459-5138AFF1-FB76-4A4F-AB64-8D84FB85AEBCQ36607908-BA57A3FC-AB84-48A4-A4EB-5DA5FD25791BQ36825354-D8FC572B-6E6D-4B6D-934A-B2BED51EE68FQ36850338-292C619E-B1BA-4A94-8EBB-4E0D395C68BEQ36945362-86AF5173-8CD4-439D-B877-35B677AF7192Q37058166-1ED46CAF-1039-4FEE-9A84-E890AFC8F658Q37240141-3EEA0E98-2160-458B-A660-3DD475454B54Q37273948-4E5F13E6-33FE-495E-91DB-85E281B000CDQ37754962-2DE2AF73-B686-4B1F-97FE-8A4B42D0E917Q37998000-F987AC7E-26DA-4067-81C8-0BB527127BD6Q38023662-C3CA5743-696F-40E2-9109-588252EE3756Q38168037-EDA53A3B-5422-44E4-B441-134D09C1B0EDQ38203257-B16D2BE5-43A9-4EB9-AD55-C5608B84BFA2Q38977392-AD9BF791-9770-411A-9AF3-AF8A028898EAQ40469736-2ECB4500-BA50-4DFA-A2A4-4206B381D71FQ44232701-54B9D3CD-D7BD-4BF6-AA20-8D8F357D5E44Q54721991-2B181C5E-1E14-49BD-8CFD-FF777A6303BFQ57299995-734278A6-D74A-402C-AE58-57D222150D44
P2860
Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recombinant gamma interferon s ...... and in tuberculosis patients.
@ast
Recombinant gamma interferon s ...... and in tuberculosis patients.
@en
Recombinant gamma interferon s ...... and in tuberculosis patients.
@nl
type
label
Recombinant gamma interferon s ...... and in tuberculosis patients.
@ast
Recombinant gamma interferon s ...... and in tuberculosis patients.
@en
Recombinant gamma interferon s ...... and in tuberculosis patients.
@nl
prefLabel
Recombinant gamma interferon s ...... and in tuberculosis patients.
@ast
Recombinant gamma interferon s ...... and in tuberculosis patients.
@en
Recombinant gamma interferon s ...... and in tuberculosis patients.
@nl
P2093
P2860
P1476
Recombinant gamma interferon s ...... and in tuberculosis patients.
@en
P2093
Antony Canova
Ben-Yang Zhao
Bindu Raju
Michael Weiden
Rany Condos
Richard Pine
William N Rom
P2860
P304
P356
10.1128/IAI.71.4.2058-2064.2003
P407
P577
2003-04-01T00:00:00Z